Cargando…

Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation

Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeiffer, Christoph J., Gehl, Hans-Björn, Scholtz, Lars-Uwe, Goon, Peter, Sudhoff, Holger, Todt, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296110/
https://www.ncbi.nlm.nih.gov/pubmed/37371333
http://dx.doi.org/10.3390/brainsci13060853
_version_ 1785063580227338240
author Pfeiffer, Christoph J.
Gehl, Hans-Björn
Scholtz, Lars-Uwe
Goon, Peter
Sudhoff, Holger
Todt, Ingo
author_facet Pfeiffer, Christoph J.
Gehl, Hans-Björn
Scholtz, Lars-Uwe
Goon, Peter
Sudhoff, Holger
Todt, Ingo
author_sort Pfeiffer, Christoph J.
collection PubMed
description Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be evaluated by magnet resonance imaging (MRI). Bilateral MD occurs in 10–33% and can be the reason for a postoperative persisting or newly occurring vertigo in this group. Recent developments in the field of implant magnets and experience in MRI sequences allow the diagnostic performance of MRI in cochlear implantees to be evaluated. The aim of the present study was to evaluate the possibility of MRI as a visual diagnostic tool for endolymphatic hydrops in cochlear implantees. Material and Methods: This was a retrospective study including three cochlear implantees (age: 61–76 years, one female, two male) suffering from MD who, postoperatively, had a recurrence of vertigo with Ménière’s-like symptoms. An MRI was performed for the evaluation of ELH (ELH-MRI). MRI observation was performed by a 4 h iv. delayed Gad 3 D Flair sequence. Results: In all cases, the ipsilateral implant magnet artifact covered the vestibulum, the semicircular canals and the cochlea. The contralateral vestibulum, the semicircular canal and the cochlea were fully observable, and a classification of the ELH-MRI could be performed. Conclusion: ELH-MRI scanning allows for the detection of contralateral labyrinthine endolymphatic hydrops and is a tool for the postoperative evaluation of vertigo in cochlear implantees.
format Online
Article
Text
id pubmed-10296110
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102961102023-06-28 Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation Pfeiffer, Christoph J. Gehl, Hans-Björn Scholtz, Lars-Uwe Goon, Peter Sudhoff, Holger Todt, Ingo Brain Sci Communication Introduction: Cochlear implantation in patients with Ménière’s disease (MD) is the treatment of choice in cases of functional deafness. Additional vertigo control is of central importance in this group of patients. Endolymphatic hydrops (ELH) is the pathophysiological correlate of MD and can be evaluated by magnet resonance imaging (MRI). Bilateral MD occurs in 10–33% and can be the reason for a postoperative persisting or newly occurring vertigo in this group. Recent developments in the field of implant magnets and experience in MRI sequences allow the diagnostic performance of MRI in cochlear implantees to be evaluated. The aim of the present study was to evaluate the possibility of MRI as a visual diagnostic tool for endolymphatic hydrops in cochlear implantees. Material and Methods: This was a retrospective study including three cochlear implantees (age: 61–76 years, one female, two male) suffering from MD who, postoperatively, had a recurrence of vertigo with Ménière’s-like symptoms. An MRI was performed for the evaluation of ELH (ELH-MRI). MRI observation was performed by a 4 h iv. delayed Gad 3 D Flair sequence. Results: In all cases, the ipsilateral implant magnet artifact covered the vestibulum, the semicircular canals and the cochlea. The contralateral vestibulum, the semicircular canal and the cochlea were fully observable, and a classification of the ELH-MRI could be performed. Conclusion: ELH-MRI scanning allows for the detection of contralateral labyrinthine endolymphatic hydrops and is a tool for the postoperative evaluation of vertigo in cochlear implantees. MDPI 2023-05-25 /pmc/articles/PMC10296110/ /pubmed/37371333 http://dx.doi.org/10.3390/brainsci13060853 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Pfeiffer, Christoph J.
Gehl, Hans-Björn
Scholtz, Lars-Uwe
Goon, Peter
Sudhoff, Holger
Todt, Ingo
Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title_full Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title_fullStr Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title_full_unstemmed Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title_short Endolymphatic Hydrops Magnet Resonance Imaging in Ménière’s Disease Patients after Cochlea Implantation
title_sort endolymphatic hydrops magnet resonance imaging in ménière’s disease patients after cochlea implantation
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296110/
https://www.ncbi.nlm.nih.gov/pubmed/37371333
http://dx.doi.org/10.3390/brainsci13060853
work_keys_str_mv AT pfeifferchristophj endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation
AT gehlhansbjorn endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation
AT scholtzlarsuwe endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation
AT goonpeter endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation
AT sudhoffholger endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation
AT todtingo endolymphatichydropsmagnetresonanceimaginginmenieresdiseasepatientsaftercochleaimplantation